Influence of intratumour heterogeneity in the interpretation of marker results in phaeochromocytomas
Krijger et al.1 try to predict the clinical behaviour of a phaeochromocytomas (PCCs) on the basis of the immunoreactivity of three markers (p53, bcl-2, and c-erbB-2). They conclude that the co-expression of p53 and bcl-2 proteins may assist that prediction. Our own preliminary results2,3 mainly agree with theirs and point towards two interrelated biological issues: firstly, the clonal evolution of neo- plasms and intratumour heterogeneity of markers; and secondly, the importance of apoptosis in tumour initiation and progression.
Krijger et al. clearly indicate the importance of p53 and bcl-2 in the pathogenesis of a subgroup of PCCs. However, the variability of marker expression and the potential relationship with kinetic features are also helpful in understanding the pathogenesis of PCC.
You must be logged in to post comments.
You claim request was sent. I will be handled in the next 24 hours.Close window